Staar Surgical Stock Alpha and Beta Analysis
| STAA Stock | USD 23.09 0.12 0.52% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as STAAR Surgical. It also helps investors analyze the systematic and unsystematic risks associated with investing in STAAR Surgical over a specified time horizon. Remember, high STAAR Surgical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to STAAR Surgical's market risk premium analysis include:
Beta 0.18 | Alpha (0.18) | Risk 3.53 | Sharpe Ratio (0.06) | Expected Return (0.20) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out STAAR Surgical Backtesting, STAAR Surgical Valuation, STAAR Surgical Correlation, STAAR Surgical Hype Analysis, STAAR Surgical Volatility, STAAR Surgical History and analyze STAAR Surgical Performance. STAAR Surgical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. STAAR Surgical market risk premium is the additional return an investor will receive from holding STAAR Surgical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in STAAR Surgical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate STAAR Surgical's performance over market.| α | -0.18 | β | 0.18 |
STAAR Surgical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of STAAR Surgical's Buy-and-hold return. Our buy-and-hold chart shows how STAAR Surgical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.STAAR Surgical Market Price Analysis
Market price analysis indicators help investors to evaluate how STAAR Surgical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading STAAR Surgical shares will generate the highest return on investment. By understating and applying STAAR Surgical stock market price indicators, traders can identify STAAR Surgical position entry and exit signals to maximize returns.
STAAR Surgical Return and Market Media
The median price of STAAR Surgical for the period between Fri, Oct 3, 2025 and Thu, Jan 1, 2026 is 26.21 with a coefficient of variation of 4.78. The daily time series for the period is distributed with a sample standard deviation of 1.24, arithmetic mean of 25.86, and mean deviation of 1.01. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Can STAAR Surgical Company stock continue upward trend - Weekly Trade Review Trade Opportunity Analysis Reports - newser.com | 10/30/2025 |
2 | Disposition of 20967 shares by Jiang Wei of STAAR Surgical subject to Rule 16b-3 | 11/12/2025 |
3 | Acquisition by Broadwood Partners, L.p. of tradable shares of STAAR Surgical subject to Rule 16b-3 | 11/20/2025 |
4 | Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon | 12/11/2025 |
5 | Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against | 12/12/2025 |
6 | STAAR Surgical gains as proxy adviser ISS supports revised Alcon deal | 12/16/2025 |
7 | Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails | 12/17/2025 |
8 | Exclusive STAAR merger with Alcon still fails to gain traction, only 30 percent vote for | 12/19/2025 |
9 | Is STAAR Surgical A Bargain After Years of Share Price Declines | 12/23/2025 |
10 | New 17 Million Bet on STAAR Surgical Comes as Sales Jump 7 percent and Margins Hit 82 | 12/30/2025 |
About STAAR Surgical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including STAAR or other stocks. Alpha measures the amount that position in STAAR Surgical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2016 | 2021 | 2022 | 2025 (projected) | Days Sales Outstanding | 78.67 | 73.73 | 92.16 | 52.14 | PTB Ratio | 18.32 | 16.67 | 2.99 | 26.03 |
STAAR Surgical Upcoming Company Events
As portrayed in its financial statements, the presentation of STAAR Surgical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of STAAR Surgical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of STAAR Surgical. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with STAAR Surgical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out STAAR Surgical Backtesting, STAAR Surgical Valuation, STAAR Surgical Correlation, STAAR Surgical Hype Analysis, STAAR Surgical Volatility, STAAR Surgical History and analyze STAAR Surgical Performance. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
STAAR Surgical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.